7 BIBLIOGRAPHY - INFLIBNETshodhganga.inflibnet.ac.in/bitstream/10603/50606/7/18...BIBLIOGRAPHY 179 7...

BIBLIOGRAPHY

179

7 BIBLIOGRAPHY

A. A. Attama, P. A. Akpa, L. E. Onugwu, G. Igwilo;(2008). Novel buccoadhesive

delivery system of hydrochlorothiazide formulated with ethyl cellulose

-hydroxypropyl methylcellulose interpolymer complex, Scientific Research and

Essay; 3(6):343-347.

A. E. Benson; (2005). Transdermal drug delivery; Penetration enhancement techniques;

Current drug delivery; 2: 23-33.

Aiman A. Obaidat, Rana M. Obaidat;(2011). Development and evaluation of fast-

dissolving tablets of Meloxicam- β-cyclodextrin complex prepared by direct

compression, Acta Pharm; 61(1):83–91.

Alfred Martin, James Swarbrick, Arthur Cammarata;(1991). Polymer Science, In chapter

22 of, Physical Pharmacy: Physical chemical principles in the pharmaceutical

sciences, 3rd Indian ed., K. M. Varghese Company, Bombay; 614-616.

Amit Chaudhary, Upendra Nagaich, Neha Gulati, V. K. Sharma, R. L. Khosa;(2012).

Enhancement of solubilization and bioavailability of poorly soluble drugs by

physical and chemical modifications: A recent review, Journal of Advanced

Pharmacy Education and Research; 2(1):32-67.

Azmail Khan, Syed Sanaullah, Md. Liyakat Ahmed, Aejaz Ahmed;(2010). In -vivo

efficacy study of Aceclofenac solid dispersion incorporated gels for transdermal

delivery on Rats, Asian J. Exp. Biol. Sci.; 1(3):602-5.

BIBLIOGRAPHY

180

B AnilReddy;(2010), In-vitro characterization and evaluation of transdermal drug

delivery system for Metoprolol Tartarate. Journal of Pharmaceutical Research and

Health Care; 2(4):325-329.

B. C. Finnin, T. M. Morgan;(1999). Transdermal penetration enhancers: limitations, and

potential. Journal of Pharmaceutical Sciences; 88:955 – 958.

B. J. Thomas, B. C. Finnin;(2004). The transdermal revolution, Drug Discovery Today;

9, 697 - 703.

Banakar U. V., Swarbrick J.;(1992). Drug and Pharmaceutical Sciences, 49, Marcel

Dekker, New York, 407.

Bellantone N.H., Rim S., Rasadi B.;(1980). Enhanced percutaneous absorption via

Iontophoresis. Evaluation of an in-vitro system and transport of model compound.,

Int. J. Pharm.; 30, 63-72.

Bharadwaj R, Dorr RT, Blanchard J.;(2000). Approaches to reducing toxicity of

parenteral anticancer drug formulations using cyclodextrins. J. Pharm. Sci. Technol;

54:233–9.

Bharkatiya M., Nema R. K.;(2006). Designing and evaluation of patches of Nimesulide,

Asian J. Pharm.; 1(1):46-48.

Bhattacharya A, Ghosal S.K.;(2000). Preparation of matrix type transdermal drug

delivery of Ketotifen Fumarate, Eastern Pharmacist; (3):109-11.

Bodor, N.S.; Huang, M-J.; Watts, J.D; (1995) Theoretical studies on the structures of

natural and alkylated cyclodextrins. J. Pharm. Sci.; 84(3), 330-336.

BIBLIOGRAPHY

181

Botsi, A.; Yannakopoulou, K.; Perly, B.; Hajoudis;(1995), Positive or Adverse Effects of

Methylation on the Inclusion Behaviour of Cyclodextrins. A Comparative NMR

Study Using Pheromone Constituents of the Olive Fruit Fly, E. J. Org. Chem.;

60(13), 4017-4023.

Bouchemal K., Briançon S., Fessi H., Chevalier Y. , Bonnet I., Perrier E.;(2006).

Simultaneous emulsification and interfacial polycondensation for the preparation of

colloidal suspension of nanocapsules, Material Science and Engineering; 26(2-3),

472–480.

Brandner, J.M., Kief, S., Grund, C., Rendl, M., Houdek, P., Kuhn, C., Tschachler, E.,

Franke, W.W., Moll, I.;(2002). Organization and formation of the tight junction

system in human epidermis and cultured keratinocytes. Eur. J. Cell. Biol.; 81:253–

263.

Chakole C M, Shende M A, Khadatkar S N;(2009). Formulation and development of

novel combined Halobetasol propionate and Fusidic acid ointment, Int. J. Chem.

Tech. Res.; 1(1): 103–116.

Charro B.D., Guy R.H.;(2001). Transdermal drug delivery in Drug delivery & targeting,

Hillery A. M., Lloyd A.W., Swarbrik J. edition I., Published by Taylor & Francis.

NY, US, 216-217.

Chen K., Schmidt C F.;(1925). The action of ephedrine, the active principle of Chinese

drug, J. Pharmacology. Exp. Ther.; 24:339-357.

Chien Y W.;(2009). Drugs and the Pharmaceutical Sciences: Novel drug delivery system.

2nd edition. Informa Healthcare; 50:301-375.

BIBLIOGRAPHY

182

Chien Y.W.;(1991). Systemic delivery of pharmacologically active molecules across skin

in Targeted drug delivery, Radolph L., Juliano(Editor) Springer- Verlag, Berlin, 182-

230.

Chien Yie.W.;(1988). Drug delivery polymers used in the development of transdermal

delivery system. Indian Journal of Pharmaceutical Sciences; 3(4):50-63.

Chiou WL;(1977). Pharmaceutical applications of solid dispersion systems: X-ray

diffraction and aqueous solubility studies on Griesofluvin-polyethylene glycol 6000

systems. J Pharm Sci.; 66:989-91.

Couvreur P., Barrat G., Fattal E., Legrand P., Vauthier C.;(2002). Nanocapsule

technology, Critical Reviews in Therapeutic Drug Carrier Systems, 19(2), 99-134.

D. P. Patel; (2011). Formulation and evaluation aspects of transdermal drug delivery

system. International Journal of Pharmaceutical Research and Development.;6 (2) :

83-90.

Danester Quiñones, M S; Evone S. Ghaly;(2008). Formulation and characterization of

Nystatin gel, Puerto Rico Health Sciences Journal; 27(1):61-7.

David C. Bibby, Nigel M. Davies, Ian G. Tucker;(2000). Mechanisms by which

cyclodextrins modify drug release from polymeric drug delivery systems,

International Journal of Pharmaceutics; 197, 1(2):1–11.

Deepthi Mathew;(2009). A study on suitability of Nimesulide-betacyclodextrin complex

in oral and topical dosage forms, International Journal of Pharmacy and

Pharmaceutical Sciences; 1(1):193-198.

BIBLIOGRAPHY

183

Degner, F., Sigmund, R., Zeidler, H.;(2000). Efficacy and tolerability of Meloxicam in an

observational, controlled cohort study in patients with rheumatic disease, Clinical

Therapeutics; 22: 400–410.

Dey S, Malgope A;(2010). Preparation of Carvedilol transdermal patch and the effect of

Propylene Glycol on permeation, International Journal of Pharmacy and

Pharmaceutical Sciences; 2(1):137-143.

Draize J H, Woodard G, Calvery H O;(1944). Methods for the study of irritation and

toxicity of substances applied topically to the skin and mucous membranes, J

Pharmacol Exp Ther; 82:377–390.

Dufosse L, Souchon I, Feron G, Latrasse A, Spinnler H E.;(1999). In situ detoxification

of the fermentation medium during gamma-decalactone production with the yeast

Sporidiobolus salmonicolor. Biotechnol Prog;15:135–9.

E M Martin Del Valle;(2004). Cyclodextrins and their uses: A review. Process

Biochemistry; 39: 1033-1046.

El-Gamal M I, Bayomi S M, El-Ashry S M, Said S A, Abdel-Aziz A A, Abdel-Aziz N I;

(2010). Synthesis and anti-inflammatory activity of novel (substituted) benzylidene

acetone oxime ether derivatives: molecular modeling study. European Journal of

Medicinal Chemistry; 45: 1403-1414.

Elias, P M;(1981), Epidermal lipids, membranes, and keratinization, Int. J. Dermatol.;

20:1-19.

BIBLIOGRAPHY

184

Elias, P.M., Cooper, E.R., Korc, A., Brown, B.E.;(1981). Percutaneous transport in

relation to stratum corneum structure and lipid composition. J. Invest. Dermatol.; 76:

297–301.

Engelhardt G, Bogel R, Schnitzer C, Utzmann R.;(1996). Meloxicam: Influence on

Arachidonic acid metabolism. Biochemical Pharmacology; 51(1), 21-8.

Engelhardt G, Homma D, Schlegal K, Utzmann R, Schinitzler C.;(1995). Anti-

inflammatory, analgesic, antipyretic and related properties of Meloxicam, a new

non-steroidal anti-inflammatory agent with favourable gastro intestinal tolerance.

Inflamm Res.; 44:423-33.

Eseldin K, Rakesh K S, Esmaeil B M, Abd-alkadar Z A.;(2002). Transdermal drug

delivery system – Design and evaluation, International Journal of Advances in

Pharmaceutical Sciences; (1), 201-211.

Eskandar Moghimipour, Mohammad Ali Dabbagh, Anayattollah Salimi, Bahareh Rezaee,

Behzad Ehdaie;(2012). Characterization of Glycolic Acid transdermal gel: The

impact of polymeric base and co-solvent on release pattern, Journal of

Pharmaceutical and Biomedical Sciences; 2(5):53-58.

Fahmy, M.;(2006). Ca-alginate beads loaded with Meloxicam: effect of alginate

chemical composition on the properties of the beads and ulcerogenicity of the drug.

Journal of Drug Delivery Science and Technology; 16, 183–189.

Frank M M, Fries L F;(1991). The role of complement in inflammation and phagocytosis.

Immunology Today; 12: 322-326.

BIBLIOGRAPHY

185

Franklin P X, Pillai A D, Rathod P D, Yerande S, Nivsarkar M, Padh H, Vasu K K,

Sudarsanam V.;(2008). 2-Amino-5-thiazolyl motif: a novel scaffold for designing

anti-inflammatory agents of diverse structures. European Journal of Medicinal

Chemistry; 43: 129-134.

French, D.; Pulley, A. O.; Effenberger, J. A.; Rougvie, M. A.; Abdullah, M. Arch.;

(1965). Studies on the Schardinger dextrins. XII. The molecular size and structure of

the delta-, epsilon-, zeta-, and eta-dextrins. Biochem. Biophys.;111(1):, 153-160.

Fromming, K.H.; Szejtli, J.;(1994). Cyclodextrins in Pharmacy; Kluwer Acad. Publ.:

Dordrecht, 13-15.

Fujishima N, Kusaka K, Umino T, Urushinata T, Terumi K.;(2001). Flour based foods

containing highly branched cyclodextrins. Japanese Patent JP 136,898.

Gambero, A., Becker, T. L., Zago, A. S., De Oliveira, A. F., Pedrazzoli JR., J. ;(2005).

Comparative study of anti-inflammatory and ulcerogenic activities of different

cyclo-oxygenase inhibitors, Inflammopharmacology; 13(5): 441–454.

Gros L., Clark W.E., (1980). The structure of skin in The tissue of the body, Le Gros and

Clark W. E., edition VI, ELBS and Oxford University Press, London, 29-3.

Gupta G.D., Gaud R.S.;(2005) . Release rate of Tenoxicam from acrypol gels, The

Indian Pharmacist; 69-75.

Gupta, S. K., Bansal, P., Bhardwaj, R. K., Jaiswai, J., Velpandian, T;(2002). Comparison

of analgesic and anti-inflammatory activity of Meloxicam gel with Diclofenac and

Piroxicam gel in animal models: Pharmacokinetic parameters after topical

application, Skin Pharmacology and Applied Skin Physiology, 15:105–111.

BIBLIOGRAPHY

186

Hamza Y S, Aburahma M H;(2009). Design in-vitro evaluation of novel sustained release

double layer tablets of Lornoxicam: Utility of cyclodextrin and xanthan gum

combination. AAPS Pharm SciTech. 10(4): 1357-1367.

Hanft, G., Turck, D., Scheuerer, S., Sigmund, R.;(2001). Meloxicam oral suspension: a

treatment alternative to solid Meloxicam formulations, Inflammation Research,

50(13), 35–37.

Hashimoto, H.;(1991). In New trends in cyclodextrins and derivatives; Ducheˆne, D. Ed.;

Edition de Sante´, Paris, 3, 97-156.

Hedges R A.;(1998). Industrial applications of cyclodextrins. Chem Rev; 98:2035–44.

Higuchi T., (1963). Theoretical Analysis of rate of release of medicaments from ointment

bases containing in Solid Matrices, J. Pharm. Sci., 52, 1145- 1149.

Higuchi T., Connors K. A.;(1965). Phase solubility techniques, Adv. Anal. Chem.

Inatrum. 4:170-210.

Higuchi, T.; Connors, K. A.;(1965). In Advances in Analytical Chemistry and

Instrumentation; Reilly, C. N., Ed.; Wiley-Interscience: New York, 4:117-212.

Holland L, Rizzi G, Malton P;(1999). Cosmetic compositions comprising cyclic

oligosaccharides and fragrance. PCT Int Appl WO 67,716.

Howard C. Ansel, Loyd V. Allen, Jr., Nicholas G., Popovich;(2000). Disperse systems,

Ch. 13., in Pharmaceutical dosage forms and Drug delivery systems, 7th ed.,

Lippincott Williams and Wilkins, Philadelphia, 375.

Howard C. Ansel, N.G. Popovich, Allen, V. Loyd; (2005). Pharmaceutical Dosage Forms

and Drug Delivery Systems, 8th Edn., B. I. Publications Pvt. Ltd., 2005, 418.

BIBLIOGRAPHY

187

ICH Guidelines, Stability testing of new drug substances and products, 27th October

(1993).

Jain N K, Jain S, Bhadra D;(2010). Transfersomes – A novel carrier for effective

transdermal drug delivery. In: Jain N K. Controlled and novel drug delivery. 1st

edition, CBS publisher and Distributors Pvt. Ltd. 426-448.

Jantharaprapap, R., Stagni, G. ; (2007). Effects of penetration enhancers on in-vitro

permeability of Meloxicam gels, International Journal of Pharmaceutics,

343(1):26–33.

Jung S.;(2003). Novel compounds for skin penetration enhancement, The UCI

Undergraduate Research Journal,5(1):25-29.

K V. Vilegave, S P. Hiremath, P M. Chandankar, M S. Sanap, V T. Sathe, A V. Patil, M.

Kharjul;(2012). Formulation, characterization and evaluation (in-vivo-in-vitro study)

of matrix type Transdermal patches of Carvedilol; International Journal of Research

in Pharmacy and Chemistry, 2(3): 828-852.

Kadam S S, Mahadik K R, Bothara K G.;(2008). Principles of Medicinal Chemistry. 18th

edition. Nirali Prakashan.; 2: 255-273.

Kandavilli S, Nair V, Panchagnula R, (2002). Polymers in transdermal drug delivery

systems. Pharmaceutical Technology; May: 62-80.

Kanikannan N, Kandimalla K, Lamba S S, Sing M; (1999). Structure activity relationship

of chemical permeation enhancers in transdermal drug delivery; Current Med. Chem.

6(7): 593-608.

BIBLIOGRAPHY

188

Kassuya C A, Cremoneze A, Barros L F L, Simas A S, Lapa F R, Mello-Silva R,

Stefanello M E, Zampronio A R;(2009). Antipyretic and anti-inflammatory

properties of the ethanolic extract, dichloromethane fraction and costunolide from

Magnolia ovate (Magnoliaceae). Journal of Ethnopharmacology; 124:369-376.

Kim H., Lee I.;(2007). A novel drug delivery system design for Meloxicam, J. Pharm

Pharmaceut Sci, 10 (3), 288-298.

Kinne R W, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester G R;(2000).

Macrophages in rheumatoid arthritis. Arthritis Research, 2: 189-202.

Kooriyattil Naseera, C I Sajeeth, K Santhi;(2012). Formulation, optimization and

evaluation of matrix type of transdermal system of Simvastatin using permeation

enhancers; International Journal of Current Pharmaceutical Research, 4(2):79-87.

Korsmeyer R W, Gurny R, Doelker E, Buri P., Peppas N A;(1983). Mechanisms of solute

release from porous hydrophilic polymers, International Journal of Pharmaceutics,

15(1), 25-35.

Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., Couvreur P.;(2000).

Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel

colloidal carrier for the delivery of oligonucleotides, Pharmaceutical Research,

17(6), 707-714.

Lampe, M.A., Burlingame, A.L., Whitney, J., Williams, M.L., Brown, B.E., Roitman, E.,

Elias, P.M.;(1983). Human stratum corneum lipids: characterization and regional

variations. J. Lipid Res., 24:120–130.

BIBLIOGRAPHY

189

Langbein, L., Grund, C., Kuhn, C., Praetzel, S., Kartenbeck, J., Brandner, J.M., Moll, I.

Franke,W.W.;(2002).Tight junctions and compositionally related junctional

structures in mammalian stratified epithelia and cell cultures derived there from.

Eur. J. Cell Biol., 81:419-35.

Lenuţa-Maria Miclea, Lavinia Vlaia, V. Vlaia, Daniel L. Hădărugă, Constantin Mircioiu;

(2010). Preparation and characterization of Inclusion complexes of Meloxicam and

α-cyclodextrin and β-cyclodextrin, Farmacia, 58(5):583-93.

Lipscomb, G. R., Wallis, N., Armstrong, G., Rees, W. D. W.;(1998). Gastrointestinal

tolerability of Meloxicam and Piroxicam: A double-blind placebo controlled study,

Brazilian Journal of Clinical Pharmacology, 46:133–137.

Loftsson T, Brewster M E.;(1996). Pharmaceutical applications of cyclodextrins: Drug

solubilisation and stabilization. J Pharm Sci,85:1017–25.

Loftsson T, Duchene D.;(2007). Cyclodextrins and their pharmaceutical applications. Int

J of Pharm.; 329: 1–11.

Loftsson T, Ólafsdóttir B J, Fridriksdóttir H, Jónsdóttir S.;(1993). Cyclodextrin

complexation of NSAIDs: Physicochemical characteristics. Eur J Pharm Sci;1:95–

101.

Loftsson T, Stefansdottir Ó, Fridriksdottir H, Gudmundsson Ö.;(1992). Interaction

between preservatives and 2-hydroxypropyl-β-cyclodextrin, Drug Dev. Ind.

Pharm;18(13):1477–84.

Loftsson, T., Masson, M.; (2001). Cyclodextrins in topical drug formulations: Theory and

Practice. Int J Pharm.; 225:15-30.

BIBLIOGRAPHY

190

Lucas S M, Rothwell N J, Gibson R M;(2006). The role of inflammation in CNS injury

and disease. British Journal of Pharmacology; 147: 232-240.

M Najmuddin, A A Mohsin, Tousif Khan, V Patel, S Shelar;(2010). Formulation and

evaluation of solid dispersion incorporated gel of Ketoconazole, Research Journal of

Pharmaceutical, Biological and Chemical Sciences, 1(2):406-12.

M. Aqil, Y. Sultana, A. Ali.;(2006). Transdermal delivery of β-blockers. Expert opinion,

3: 405-418.

Malay K. Das, A. Bhattacharya., S. K. Ghosal.;( 2006). Transdermal delivery of

Trazodone hydrochloride from acrylic films prepared from aqueous extract, Ind. J.

Pharm Sci., 68(1):41-46.

M. R. Prausnitz, S. Mitragotri, R. Langer;(2004). Current status and future potential of

transdermal drug delivery. Nat. Rev. Drug Discov., 3: 115-124.

M. V. Nagabhushanam;(2010). Formulation studies on cyclodextrin complexes of

Meloxicam. International Journal of Pharmacy and Technology; 2(1), 89-102.

Maincent P., Le Verge R, Sado P., Couvreur P., Devissaguet J.P.;(1986). Disposition

kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate

nanoparticles, Journal of Pharmaceutical Science; 75(10),955 - 958.

Manivannan Rangasamy, Ayyasamy Balasubramaniam, Sandeep Gummadevelly;(2008).

Design and Evaluation of β-cyclodextrin Complexes of Meloxicam Tablet, Research

J. Pharm. and Tech.; 1(4):484-6.

BIBLIOGRAPHY

191

Manvi F V, Dandagi P M, Gadad A P, Mastiholimath V S, Jagadeesh T;(2003).

Formulation of a transdermal drug delivery system of Ketotifen fumarate, Indian J

Pharm Sci; 65(3):239-43.

Mario G., Gabriele G.;(2005). Mathematical Modelling and Controlled Drug Delivery:

Matrix Systems, Current Drug Delivery, 2, 97-116.

Masson, Thorstein, Loftsoon, Gisli Masson, Einar Stefansson;(1999). Cyclodextrins as

permeation enhancers; Some theoretical evaluations and in-vitro testing, Journal of

Control Release; 59(1),107-18.

Mbela T.K.M., Poupaert J.H., Dumont P.;(1992). Poly (diethylmethyldene malonate)

nanoparticles as primaquine delivery system to liver, International Journal of

Pharmacy; 79(1), 29-38.

Misra A N., (2004). Transdermal drug delivery. In: Jain N K. Controlled and novel drug

delivery. 1st edition. CBS publisher and Distributors Pvt. Ltd. 100-130.

Miyazawa H, Ueda H, Nagase T, Endo T, Kobayashi S, Nagai T.;(1995).

Physicochemical properties and inclusion complex formation of δ-cyclodextrin. Eur

J Pharm Sci.;3:153-162.

Mohd. Amjad, Mohd. Ehtheshamuddin, S. Chand, Hanifa, M. Sabreesh1, R. Asia, G. S

Kumar;(2011). Formulation and evaluation of transdermal patches of Atenolol,

Advance research in Pharmaceuticals and Biologicals; 1(2):109-19.

Montasser I., Fessi H., Coleman A.W.;(2002). Atomic force microscopy imaging of

novel type of polymeric colloidal nanostructures, European Journal of

Pharmaceutics and Biopharmaceutics; 54(3), 281-284.

BIBLIOGRAPHY

192

Morita, K., Itoh, M., Saitou, M., Ando-Akatsuka, Y., Furuse, M., Yoneda, K., Imamura,

S., Fujimoto, K., Tsukita, S.;(1998). Subcellular distribution of tight junction

associated proteins (occludin, ZO-1, ZO-2) in rodent skin. J. Invest. Dermatol.; 110:

862–866.

Muñoz-Botella S, Del Castillo B, Mart˝yn M A.;(1995). Cyclodetrin properties and

applications of inclusion complex formation. Ars Pharm; 36:187–98.

Murthy S N; Hamsa V, Bhaskaran;(1995). Comparative release studies of transdermal

films of Terbutaline sulphate across various diffusion barriers. Ind J Pharm Sci.;

57(5); 207-9.

Mutimer M N, Reffkin C, Hill J A, Marry E, Glickman M., Cry G N;(1956). Modern

ointment base technology II. J. Am. Pharm. Assoc. Sci;, 45:212-20.

N. K. Jain, A. N. Misra;(2005).Controlled and Novel Drug Delivery, CBS Publishers and

Distributors, New Delhi,

Nash, R. A; (1994). In Handbook of Pharmaceutical Excipients; Wade, A., Weller, P. J.,

Eds.; Am. Pharm. Assoc. & Phar. Press: London, 145-148.

Nathan C;(2002). Points of control in inflammation. Nature; 420: 846-852.

Nayak S H, Nakhat P D, Yeole P G;(2004). Transdermal drug delivery system. Indian

Pharmacist; 3(27):7-14.

Nelson H.S;(1995). Beta adrenergic bronchodilator, N. Eng. J. Med.; 333(8): 499-506.

BIBLIOGRAPHY

193

Nikhil Kasliwal, Dilip Derle, Jeetendra Negi, Kushal Gohil;(2010). Effect of permeation

enhancers on the release and permeation kinetics of Meloxicam gel formulations

through rat skin. Asian Journal of Pharmaceutical Sciences; 3(5):193-199.

Nirav S Sheth, Rajan B Mistry;(2011). Formulation and evaluation of transdermal

patches and to study permeation enhancement effect of Eugenol; Journal of Applied

Pharmaceutical Science; 1(3):96-101.

Obaidat A. A., Khanfar R. A., Khawam M. N.;(2011). The effect of β-cyclodextrin on the

solubility and dissolution rate of Meloxicam and investigation of the driving force

for complexation using molecular modeling, J. Incl. Phenom. Macrocycl. Chem.;

63(3):273-279.

Parthasarathy G, Bhaskar Reddy K, Prasanth V V;(2011). Formulation and

characterization of transdermal patches of Naproxen with various polymers,

Pharmacie Globale International Journal of Comprehensive Pharmacy; 2(6):1-3.

Patel D, Patel N, Parmar M, Kaur N(2011), Transdermal drug delivery system: Review.

International Journal of Biopharm and Toxicological Research; 1(1): 61-80.

Patel N B, Sonpal R N, Mohan S, Selvaraj S;(2010). Formulation and evaluation of

iontophoretic transdermal delivery of Diltiazem Hydrochloride, Int. J. Res. Pharm.

Sci.; 1(3):338-344.

Pavia D L, Lampman G M, Kriz G S;(2001). Introduction to Spectroscopy. 3rd edition.

Thomson Learning; 14-82.

BIBLIOGRAPHY

194

Pitha J, Hoshino T;(1992). Effects of ethanol on formation of inclusion complexes of

hydroxypropylcyclodextrins with testosterone or with methyl orange, Int J Pharm;

80(2):243–51.

Pitha J, Milecki J, Fales H, Pannell L, Uekama K;(1986). Hydroxypropyl-β-cyclodextrin:

preparation and characterization; effects on solubility of drugs. Int J Pharm.; 29:73–

82.

Pitha, J., Rao, C. T.,Lindberg, B., Seffers, P. ;(1990). Distribution of substituents in 2-

hydroxy propyl ethers of cyclomaltoheptaose, Carbohydr. Res.; 200, 429-435.

Pummi, K. Malminen, M.H., Aho, S.L., Karvonen, J., Peltonen, S,(2001). Epidermal

tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected

skin and in-vitro differentiating keratinocytes. J. Invest. Dermatol.; 117: 1050–1058.

R. H. Guy;(1996). Current status and future prospects of transdermal drug delivery.

Pharmaceutical Research; 13:1765-69.

Rajan Rajabalaya, Choo Hwai Qin, Sheba Rani Nakka David;(2012). Development and

in-vitro evaluation of matrix type transdermal delivery of Ondansetron

Hydrochloride; International Journal of Drug Delivery; 4(1):125-133.

Rajendrakumar K, Pralhad T, Madhusudan S;(2004). Comparative study on co-ground

products of Rofecoxib with β-cyclodextrin and its Sulfobutyl Ether-7 derivative in

solution and in the solid state. J Incl Phenom.; 49(3-4):259-266.

Rathbone M J, Hadgraft J, Roberts M S (eds.);(2004). Modified release drug delivery

technology. New York, Marcel Dekker, Inc., 126: 471-619.

BIBLIOGRAPHY

195

Reddy M N, Rehana T, Ramakrishna S, Chowdary K P R, Diwan P V;(2004).

β-cyclodextrin complexes of Celecoxib: molecular-modeling, characterization, and

dissolution studies. AAPS PharmSci.; 6(1):1-9.

Redenti, E.; Szente, L.; Szejtli, J;(2001). Cyclodextrin complexes of salts of acidic drugs

thermodynamic properties, structural features, and pharmaceutical applications, J.

Pharm. Sci.; 90(8), 979–986.

Ritschel W A, Hussain A S;(1998). The principles of permeation of substances across the

skin. Methods Find Exp Clin Pharmacol; 10(1):39-56.

Robbins, Cotran;(2005). Pathologic Basis of Disease, 7th Edition, Elsevier, 47-86.

Roux M, Perly B, Djedaini Pilard F.;(2007). Self-assemblies of amphiphilic

cyclodextrins. Eur Biophys J.; 36(8): 861–867.

Rowe R C, Sheskey P J, Quinn M E;(2009). Handbook of Pharmaceutical Excipients. 6th

edition. Pharmaceutical Press and American pharmaceutical Association; 326-329.

S. Amin, S. R. Mir, K. Kohli, A. Ali;(2012). Novel polymeric matrix films for

transdermal delivery of Metoclopramide, International Journal of Pharmaceutical

Frontier Research; 2(1):48-60.

S. Rawat;(2011). Release enhancement of Meloxicam from transdermal gel through

cyclodextrin complexation, International Journal of Pharmaceutical Sciences and

Research; 2(2):357-365.

BIBLIOGRAPHY

196

Sadhana P. Gupta, S.K. Jain;(2005). Development of transdermal delivery of Metoprolol

Tartarate, Indian Journal of Pharmaceutical Sciences; 67(3):346-50.

Sanghavi N.M., Puri R.D.;(1990). Effect of sorption promoters on the transdermal

delivery of Ibuprofen from topical bases, Indian Drugs; 28(10):1-7.

Sanjala Baboota, S P Agarwal; (2002). Inclusion complexes of Meloxicam with β-

cyclodextrin, Indian Journal of Pharmaceutical Sciences; 64(4):408-411.

Sapkal N P, Kilor V A, Bhusari K P, Daud A S.;(2007). Evaluation of some methods for

preparing Gliclazide-β-cyclodextrin inclusion complexes, Tropical Journal of

Pharmaceutical Research; 6(4):833-840.

Sathesh Babu P. R., Subrahmanyam C.V. S.; (2007). Solubility of Meloxicam in Mixed

Solvent Systems; The Ethiopian Pharmaceutical Journal; 25, 23-28

Scheindlin, Stanley;(2004). Transdermal Drug Delivery: Past, Present, Future. Molecular

Interventions. 4(6):308-312.

Schmid G.;(1989). Cyclodextrin glucanotransferse production: yield enhancement by

overexpression of cloned genes. Trends Biotechnol; 7:244–8.

Schneiderman E, Stalcup A M.;(2000). Cyclodextrins: a versatile tool in separation

science. J Chromatogr B; 745:83–102.

BIBLIOGRAPHY

197

Sharma N, Agarwal G, Rana AC, Bhat Z, Kumar D, (2011). A Review: Transdermal drug

delivery system: A tool for novel drug delivery system. International Journal of

Drug Development and Research,3(3), 70-84.

Sheth S K, Patel S J, Shukla J B;(2010). Formulation and evaluation of taste masked oral

disintegrating tablet of Lornoxicam. International Journal of Pharma and Bio

Sciences. 1(2):1-9.

Shivakumar H N, Jamakandi V G, Mulla J S, Vinay B L.;(2009). Formulation,

characterization and evaluation of matrix type transdermal patches of a model

antihypertensive drug, Asian J Pharm.; 3(1): 59-64.

Shukla Vikesh, Masareddy Rajashree, Anghore Ashok, Manvi Fakkirappa.V;(2009).

Influence of β-cyclodextrin complexation on Ketoprofen Release from Matrix

formulation, International Journal of Pharmaceutical Sciences and Drug Research;

1(3): 195-202.

Singh S, Singh J.;(1993). Transdermal drug delivery by passive diffusion and

iontophoresis: a review. Med Res Rev;13:569-621.

Somasundaram Jayaprakash, Sundarapandian Ramkanth, Posina Anitha,

Muthumanickam Alagusundaram, Mohamed T S Saleem, Madhusudhana C Chetty;

(2010). Design and evaluation of monolithic drug-in-adhesive transdermal patches

of Meloxicam, Malaysian Journal of Pharmaceutical Sciences; 8(2):25–43.

Sternon J, Appelboom; (1998). Meloxicam, Revue medicale de Bruxelles. 19(1):29-32.

BIBLIOGRAPHY

198

Subhash P. G., Dinesh B. M., Ravikumar M; (2011). Feasibility of Lercanidipine HCl For

TDDS: Permeation kinetic study in presence of various penetration enhancers,

International Journal of Pharmacy And Pharmaceutical Sciences;3(4):103-7.

Suchika Sharma, Geeta Agarwal, Sanju Dhawan;(2010). Design and evaluation of

Olanzapine transdermal patches containing vegetable oils as permeation enhancers,

Der Pharmacia Lettre, 2(6):84-98.

Swamy N. G. N., Mazhar Pasha, Zaheer Abbas;(2010). Formulation and evaluation of

Diclofenac sodium gels using Sodium Carboxymethyl Hydroxypropyl Guar and

Hydroxypropyl Methylcellulose, Indian Journal of Pharmaceutical Education and

Research; 44(4),310-14.

Szejtli J.;(1998). Introduction and general overview of cyclodextrin chemistry, Chem.

Rev.; 98(5):1743–1753.

Tanwar Y.S, Chauhan C.S, Sharma A.;(2007). Development and evaluation of Carvedilol

transdermal patches. Acta Pharm.; 57:151-159.

Tiwary A K, Sapra B, Jain S,;(2007). Innovations in Transdermal drug delivery:

Formulations and techniques. Recent Patents on Drug Delivery and Formulation; 1:

23-36.

Torres-Labandeira J J, Davignon P, Pitha J.; (1990). Oversaturated solutions of drug in

hydroxypropylcyclodextrins: parenteral preparation of pancratistatin. J Pharm Sci.;

80:384–6.

BIBLIOGRAPHY

199

Tortora G J, Derrickson B.; (2006). Principles of Anatomy and Physiology. 11th edition.

Wiley; 144-170.

Tripathi K D.; (2008). Non-steroidal anti-inflammatory drugs and antipyretic-analgesic.

In: Essentials of Medical Pharmacology. 6th edition. Jaypee Brothers Medical

Publishers (P) Ltd.; 184-210.

Udupa N.; (1992). Iontophoretic drug delivery system, Pharma Times; 24, 9-15.

V. R. Sinha, Maninder Pal Kaur,;(2000). Permeation Enhancers for Transdermal Drug

Delivery, Drug Development and Industrial Pharmacy; 26(11):1131–40.

V.N.L. Sirisha, P. Kirankumar, M. ChinnaEswaraiah; (2012). Formulation and evaluation

of transdermal patches of Propranolol Hydrochloride, IOSR Journal of Pharmacy,

2 (5): 31-37.

Villiers, M.A. ; (1891). Sur la fermentation de la fecule par l'action du ferment butyrique.

Comptes Rendus Acad. Sci. 112, 536-538.

Vinod KR, Sarvani P, Banji D, Teja BB, (2010). Transdermal drug delivery system over

coming challenges of popular drug delivery system. International Journal of

Pharma World Research, 1(3), 1-14.

Vinod L. Gaikwad, Vishal D.Yadav, Rakesh P. Dhavale, Prafulla B. Choudhari, Swapnil

D Jadhav; (2012). Effect of carbopol 934 and 940 on Fluconazole release from

topical gel formulation: A Factorial Approach, Current Pharma Research; 2(2):487-

493.

BIBLIOGRAPHY

200

Vivek Kumar R, Satish Kumar; (2011). Formulation and evaluation Of Mimosa Pudica

Gel, International Journal of Pharmacy and Pharmaceutical Sciences; 3(1):55-57.

Vodovotz Y, Csete M, Bartels J, Chang S, An G ;(2008). Translational systems biology

of inflammation. PLoS Computational Biology; 4: 1-6.

Vogel H G.; (2002). Drug Discovery and Evaluation Pharmacological assays. In chapter

H: analgesic, anti-inflammatory and anti-pyretic activity. 2nd Edition. Springer-

Verlag Heidelberg, New York; 759-61.

Vyas S.P., Khar Roop K.;(2002). Controlled Drug Delivery, 1st Edn., Vallabh Prakashan,

New Delhi.

Watnasirichaikul S., Davies N.M., Rades T., Tucker I.G.;(2002). Preparation of

biodegradable insulin nanocapsules from biocompatible microemulsions,

Pharmaceutical Research; 17(6), 684-9.

Wertz P.W., Medison K.C., Downing D.T. ; (1987). The composition & morphology of

Epidermal cyst lipids., J. Invest. Dermatol.; 89:417-425.

White M; (1999). Mediators of inflammation and inflammatory process. The Journal of

Allergy and Clinical Immunology; 103:378-381.

Williams, M L, Elias, P M; (1987). The extracellular matrix of stratum corneum: role of

lipids in normal and pathological function: Crit Rev. Ther. Drug Carrier Syst.; 3:95-

122.

BIBLIOGRAPHY

201

Xiaoping Z, Sijing C, Guochun T, Zhenmin M. ; (2007). Poly (2-hydroxy-3- phenoxy-

-propylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled

Clonidine zero-order release, The European Journal of Pharmaceutics and

Biopharmaceutics; 66:429-34.

Y. W. Chien.; (1992). Transdermal drug delivery and delivery systems, in: Y.W. Chien

(Ed), Novel Drug Delivery Systems, 2nd ed., Chapter 7, Marcel Dekker, New York,

301-380.

Yiew W. Chien; (1982). Transdermal controlled release drug administration in Novel

drug delivery system. Edition I, Marcel Dekker, NYUSA, 149-213.

Yogesh M. Amgaokar, Rupesh V. Chikhale, Updesh B. Lade, Dinesh M. Biyani, Milind

J. Umekar; (2011). Design, Formulation and evaluation of transdermal drug delivery

system of Budesonide, Digest Journal of Nanomaterials and Biostructures;

6(2):475-497.

Yu T, Lee J, Lee Y G, Byeon S E, Kim M H, Sohn E H, Lee Y J, Lee S G, Cho J Y;

(2010). In-vitro and in-vivo anti-inflammatory effects of ethanol extract from Acer

tegmentosum. Journal of Ethnopharmacology; 128:139-147.

Yuan, Y., Li, S. M., Mo, F. K., Zhong, D. F.; (2006). Investigation of microemulsion

system for transdermal delivery of Meloxicam, International Journal of

Pharmaceutics; 321(1):117–123.